CCIA
SPPI

Campbell & Co Investment Adviser’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,639
Closed -$192K – 543
2017
Q3 		$192K Buy
+13,639
New +$123K 0.16% 301
2016
Q4 		– Sell
-29,596
Closed -$138K – 212
2016
Q3 		$138K Buy
29,596
+6,146
+26% +$36.4K 0.37% 119
2016
Q2 		$154K Buy
+23,450
New +$166K 0.78% 65

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Campbell & Co Investment Adviser's SPPI Position: Q4 2017 in Review

Campbell & Co Investment Adviser sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 13,639 shares — an estimated $192K sold.

Campbell & Co Investment Adviser first reported a position in SPPI in Q2 2016 and held it in 3 quarters. The position peaked at $192K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

  • Campbell & Co Investment Adviser reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 13,639 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $192K.
  • Campbell & Co Investment Adviser first reported a position in Spectrum Pharmaceuticals Inc in Q2 2016 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Spectrum Pharmaceuticals Inc position peaked at $192K in Q3 2017.
  • 157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2017, filed 14 Feb 2018.